{"url":"https://lda.senate.gov/api/v1/filings/c3fb277b-fbcc-4d54-b9ee-1d5eadd83fa4/","filing_uuid":"c3fb277b-fbcc-4d54-b9ee-1d5eadd83fa4","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2022,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/c3fb277b-fbcc-4d54-b9ee-1d5eadd83fa4/print/","filing_document_content_type":"text/html","income":null,"expenses":"830000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Peter Wallace","dt_posted":"2022-10-20T09:22:06-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1000 Mylan Boulevard","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Canonsburg","registrant_state":"PA","registrant_zip":"15317","registrant":{"id":26353,"url":"https://lda.senate.gov/api/v1/registrants/26353/","house_registrant_id":33792,"name":"VIATRIS INC.","description":null,"address_1":"1000 Mylan Boulevard","address_2":null,"address_3":null,"address_4":null,"city":"Canonsburg","state":"PA","state_display":"Pennsylvania","zip":"15317","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PETER WALLACE","contact_telephone":"+1 202-507-5356","dt_updated":"2026-07-30T15:07:39.090404-04:00"},"client":{"id":134178,"url":"https://lda.senate.gov/api/v1/clients/134178/","client_id":12,"name":"VIATRIS INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 3 - Lower Drug Costs Now Act; Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; Generic drug quality and FDA oversight H.R. 5376 - the Inflation Reduction Act of 2022; S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022 Biosimilar interchangeability Part D Formulary Design and Generic Drug Tiering; Electronic labeling of prescription drugs H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes; FDA facility inspections S. 4338 - the Increasing Transparency in Generic Drug Applications Act S. 4351 - the Enhanced Access to Affordable Medicines Act H.R. 7559 - the Prescription Information Modernization Act of 2022; Complex Generic Drug Approvals","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66369,"prefix":null,"prefix_display":null,"first_name":"KATHARINE","nickname":null,"middle_name":null,"last_name":"HAYES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68303,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69928,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"WALLACE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72530,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"WILSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138091,"prefix":"mr","prefix_display":"MR.","first_name":"WILL","nickname":null,"middle_name":null,"last_name":"DENT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements S4417 - Patent Trial and Appeal Board (PTAB) Reform Act of 2022","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138091,"prefix":"mr","prefix_display":"MR.","first_name":"WILL","nickname":null,"middle_name":null,"last_name":"DENT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68303,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69928,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"WALLACE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66369,"prefix":null,"prefix_display":null,"first_name":"KATHARINE","nickname":null,"middle_name":null,"last_name":"HAYES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72530,"prefix":null,"prefix_display":null,"first_name":"ANNE","nickname":null,"middle_name":null,"last_name":"WILSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Trade issues related to generic medicines Pharmaceutical supply chain","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":69928,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"WALLACE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68303,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66369,"prefix":null,"prefix_display":null,"first_name":"KATHARINE","nickname":null,"middle_name":null,"last_name":"HAYES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138091,"prefix":"mr","prefix_display":"MR.","first_name":"WILL","nickname":null,"middle_name":null,"last_name":"DENT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FIN","general_issue_code_display":"Financial Institutions/Investments/Securities","description":"Policy related to corporate governance","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68303,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Corporate Tax Policy","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68303,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69928,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"WALLACE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66369,"prefix":null,"prefix_display":null,"first_name":"KATHARINE","nickname":null,"middle_name":null,"last_name":"HAYES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138091,"prefix":"mr","prefix_display":"MR.","first_name":"WILL","nickname":null,"middle_name":null,"last_name":"DENT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"VA Access to affordable medicines","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":69928,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"WALLACE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68303,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138091,"prefix":"mr","prefix_display":"MR.","first_name":"WILL","nickname":null,"middle_name":null,"last_name":"DENT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66369,"prefix":null,"prefix_display":null,"first_name":"KATHARINE","nickname":null,"middle_name":null,"last_name":"HAYES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}